Noseguard for Prevention of Respiratory Infections in Real-World Use

NCT07516977 · tracked via the Priya Life Science South Korea tracker

Sponsor

Daewoong Pharmaceutical Co. LTD

Phase

Not applicable

Started

2026-04-20

Last updated

2026-04-08

Condition(s) studied

Respiratory Infection VirusCOVID-19Influenza

Investigational drug(s) / intervention(s)

Noseguard and Noseguard Night

Noseguard and Noseguard Night: Nasal spray medical devices used to form a protective barrier on the nasal mucosa to reduce viral entry.

Study summary

This study is a prospective clinical study to evaluate the effectiveness of combined use of two nasal protective medical devices (Noseguard and Noseguard Night) in reducing respiratory infection rates, including COVID-19 and influenza, in real-world conditions.

The study will also assess usability, satisfaction, and safety using electronic patient-reported outcomes (ePRO).

Eligibility

Sex

ALL

Min age

19 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Adults aged ≥19 years * Able to provide informed consent Exclusion Criteria: * Hypersensitivity to device components * Current COVID-19 or influenza infection * Severe nasal disease * Pregnant or breastfeeding women

Primary outcome measure(s)

Incidence of Respiratory Infection — Week 8
Incidence of respiratory infections, including COVID-19 and influenza, during the 8-week study period.

Trial sites (1)

Facility	City	Region	Status
Jeonbuk University Hospital	Jeonju	South Korea

More Daewoong Pharmaceutical Co. LTD. trials in South Korea

Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia Recruiting

Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF Active, not recruiting

Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab Active, not recruiting

Observational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients With Stage Ⅰ Hypertension Recruiting

Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients Starting soon

Other trials for the same condition

Influenza Vaccination Strategy for Patients With Hematologic Malignancy Recruiting

Korea Comirnaty Post-marketing Surveillance Active, not recruiting

Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients Active, not recruiting

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study Recruiting

Immunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy Volunteers Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07516977 on ClinicalTrials.gov ↗ ← All trials in South Korea